High Negative Predictive Value.
Osteoporotic fracture risk assessment as discriminating as DXA at the hip and spine. High negative predictive value.1 Clinicians can be use Achilles EXPII in initial osteoporotic assessment before referring to a DXA scan.
A quick and comfortable exam.
Bone assessments take just a few minutes. Your patients sit comfortably during the pain-free exam—no messy gels required. Moreover, the unit emits no ionizing radiation.
Efficient customizable workflow.
Achilles units are portable and affordable. When combined with the quick exam time, these features help enable you to reach more patients. Furthermore, the user-friendly Achilles EXPII requires no special room and no formal certification. Results are concise, convenient to print on the spot and easy for the staff to interpret.
Achilles EXPII Reliability
Lunar from GE Healthcare: Best of DXA and QUS Technology. Committed to Bone and Metabolic Health.
Bone Density Test and Body Composition Scan using DXA Technology from GE Healthcare
DXA technology from GE Healthcare provides high precision and accuracy
DXA Technology from GE Healthcare: safe, reliable and lower dosage to patients
Lunar iDXA Technology from GE Healthcare provides excellent image quality
- Krieg M-A, Barkmann R, Gonnelli S, et al. Quantitative Ultrasound in the Management of Osteoporosis: The 2007 ISCD Official Positions. J Clin Densitom: Assessment of Skeletal Health. 2008; 11 (1): 163-187.
- Simon D, Boring III JR. Chap. 6: Sensitivity, Specificity, and Predictive Value. In: HK Walker, WD Hall, JW Hurst, ed. Clinical Methods: The History, Physical, and Laboratory Examinations, 3rd edition. Boston: Butterworths; 1990.
- Gonnelli S, Cepollaro C, Pondrelli C, Martini S, Rossi S, Gennari C. Ultrasound parameters in osteoporotic patients treated with salmon calcitonin: A longitudinal study. Osteoporos Int. 1996; 6 (4): 303-307.
- Giorgino R, Paparella AP, Lorusso D, Mancuso S. Effects of oral alendronate treatment and discontinuance on ultrasound measurements of the heel in postmenopausal osteoporosis. North American Menopausal Society, September 1996.
- Gonnelli S, Cepollaro C, Montagnani A, et al. Heel ultrasonography in monitoring alendronate therapy: a four-year longitudinal study. Osteoporos Int. 2002; 13 (5): 415-421.